Wells Fargo’s Profound Medical PROF Stock Holding History

Wells Fargo’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.2K	Buy	5,592 +600	+12%	+$4.14K	﹤0.01%	5561
2025 Q4	$39.3K	Buy	4,992 +208	+4%	+$1.34K	﹤0.01%	5629
2025 Q3	$23.4K	Hold	4,784	–	–	﹤0.01%	5760
2025 Q2	$28.2K	Hold	4,784	–	–	﹤0.01%	5687
2025 Q1	$27.8K	Hold	4,784	–	–	﹤0.01%	5599
2024 Q4	$35.9K	Hold	4,784	–	–	﹤0.01%	5590
2024 Q3	$38.1K	Hold	4,784	–	–	﹤0.01%	5444
2024 Q2	$40.1K	Hold	4,784	–	–	﹤0.01%	5373
2024 Q1	$40.8K	Buy	4,784 +1,413	+42%	+$11.8K	﹤0.01%	5337
2023 Q4	$28.6K	Buy	3,371 +612	+22%	+$5.81K	﹤0.01%	5502
2023 Q3	$28.1K	Hold	2,759	–	–	﹤0.01%	5461
2023 Q2	$35.9K	Buy	2,759 +1,586	+135%	+$19.7K	﹤0.01%	5558
2023 Q1	$10.9K	Buy	1,173 +173	+17%	+$2K	﹤0.01%	5839
2022 Q4	$10.9K	Hold	1,000	–	–	﹤0.01%	5517
2022 Q3	$4K	Hold	1,000	–	–	﹤0.01%	5986
2022 Q2	$7K	Hold	1,000	–	–	﹤0.01%	5901
2022 Q1	$9K	Hold	1,000	–	–	﹤0.01%	6313
2021 Q4	$11K	Hold	1,000	–	–	﹤0.01%	6505
2021 Q3	$15K	Buy	+1,000	New	+$15.2K	﹤0.01%	6071
2020 Q3	–	Sell	-300	Closed	-$5K	–	6754
2020 Q2	$5K	Hold	300	–	–	﹤0.01%	5981
2020 Q1	$3K	Buy	+300	New	+$3.89K	﹤0.01%	5949

Other funds holding PROF

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $395M AUM

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Wells Fargo's PROF Position: Q1 2026 in Review

Wells Fargo increased its Profound Medical (PROF) stake by 12% in Q1 2026, buying an estimated $4.14K and bringing the position to 5,592 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5561.

Wells Fargo first reported a position in PROF in Q1 2020 and has held it in 21 quarters since. The position peaked at $40.8K in Q1 2024. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

Wells Fargo held 5,592 shares of Profound Medical worth $36.2K as of Q1 2026.
Wells Fargo bought 600 Profound Medical shares in Q1 2026, an estimated $4.14K.
Profound Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5561 holding.
Wells Fargo first reported a position in Profound Medical in Q1 2020 and has held it in 21 quarters since.
Wells Fargo's Profound Medical position peaked at $40.8K in Q1 2024.
57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.